DALLAS, May 29 /PRNewswire/ -- BeaconEquity.com announces availability of alerts on pharmaceutical companies poised to wrap up the week with heavy trading. The alerts include recent news, trading activity and technical analysis.
Today's Stock Alerts include: Angiotech Pharmaceuticals Inc. (Nasdaq: ANPI), Peregrine Pharmaceuticals Inc. (Nasdaq: PPHM), Biogen Idec Inc. (Nasdaq: BIIB), Genzyme Corp. (Nasdaq: GENZ), Celgene Corp. (Nasdaq: CELG) and Gilead Sciences Inc. (Nasdaq: GILD).
See what Cramer has to say about these stocks and many more.
BeaconEquity.com's Stock Alerts are brief analyses on the active stocks each day that are affecting the markets. These include breaking news, insider activity, recent 52-week highs/lows, technical breakouts, and other market driving information. Beacon is the authority on research in the small-cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
BeaconEquity.com is one of the industry's largest small-cap research providers. Beacon strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on Beacon Research, please visit: http://www.BeaconEquity.com/m CRD# 2207572
BeaconEquity.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BeaconEquity.com is a Web site wholly-owned by BlueWave Advisors, LLC. Please read our report and visit our Web site, BeaconEquity.com, for complete risks and disclosures.
Beacon Equity Research Jeff Bishop, (469)-252-3505 email@example.com
David C. Masson of Beacon Equity Research is a member of the National Association of Securities Dealers, CRD number 2207572.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
Copyright©2009 PR Newswire.
All rights reserved